CE-IVDR marked digital pathology solutions expand across APAC

Indica Labs, a leader in digital pathology solutions, announces the expansion of its reseller network across the Asia Pacific (APAC) region. The company has entered into distributorship agreements with key partners: MRL Cybertec Corporation in the Philippines, Pathology Ware International in Thailand, Minh Khang Technical Service & Trading Co. Ltd. in Vietnam, and Histocenter in Malaysia. These partnerships aim to expand distribution of Indica Labs’ HALO AP®, HALO®, HALO AI, HALO Link, and HALO Clinical Solutions throughout the region.

Steven Hashagen, CEO of Indica Labs, commented: "We are excited to extend our presence in the APAC region through partnerships with experienced resellers. Their established networks and expertise in digital pathology will ensure effective deployment and support of our products."

The selected resellers bring a wealth of experience in digital pathology instrumentation and software strengthening Indica Labs’ ability to serve clinical needs and expand its customer base in APAC.

Eric Runde, COO at Indica Labs, added: "Following regulatory approvals in Europe and the USA, we are actively pursuing IVD registrations in APAC. We anticipate significant adoption of our products in the region."

Under the new agreements, APAC distributors will offer HALO AP®, a CE-IVDR marked enterprise digital pathology platform, alongside HALO Clinical AI Solutions. These solutions, including HALO Prostate AI, Lung PD-L1 AI, Breast IHC AI, and SlideQC BF, integrate seamlessly into HALO AP® for advanced image analysis and management in life sciences applications.

Maristel Abigail R. Lim from MRL Cybertec Corp stated: "As a long-standing distributor of histopathology solutions in the Philippines, we are thrilled to partner with Indica Labs. This collaboration will introduce their innovative AI technologies to enhance efficiency and workflows in histopathology labs across our country."

HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland, while HALO AI Prostate is CE-marked for similar use. Both are intended for research use only in the US and other regions.

More information online